Kiadis Pharma B.V. , a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces that its lead product inventor, , is providing the following presentation: "Donor lymphocytes selectively photodepleted of alloreactive T cells can fight infections without causing GVHD" at the Haploidentical Transplantation 2013 ... (more)
http://www.sys-con.com/node/2886282
http://www.sys-con.com/node/2886282
No comments:
Post a Comment